This is a working overview of alpha-MSH analog, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-03-10. Anything still debated is marked as such rather than presented as settled.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Analog of alpha-melanocyte-stimulating hormone |
| Primary receptor family | Melanocortin receptors MC1R through MC5R | Binding is not subtype-selective |
| Development period | 1980s | Synthesized during pigmentation and appetite research |
| Regulatory status | Not an approved medicine | No major regulator has authorized human use |
| Related compound | Afamelanotide | Linear analog studied for photoprotection |
Despite the fact that PPIs have revolutionized the treatment of GERD, there is still room for improvement in the speed of onset of acid suppression as well as mode of action that is independent of an acidic environment and also better inhibition of the proton pump. Therefore, a new class of PPIs, potassium-competitive acid blockers (P-CABs) or acid pump antagonists (APAs), have been under development since the 1980s. These agents can in a reversible and competitive fashion inhibit the final step in the gastric acid secretion with respect to K+ binding to the parietal cell gastric H+/K+ ATPase. That is, they block the action of the H+/K+ ATPase by binding to or near the site of the K+ channel. Since the binding is competitive and reversible, these agents have the potential to achieve faster inhibition of acid secretion and longer duration of action compared to PPIs, resulting in quicker symptom relief and healing. The imidazopyridine-based compound SCH28080 was the prototype of this class, and turned out to be hepatotoxic. Agents in development include CS-526, YH4808, linaprazan glurate, soraprazan and revaprazan. Studies remain to determine whether these or other related compounds can become useful. Some P-CABs have shown efficacy in clinical trials as of 2024. In June 2006, Yuhan obtained approval from the Korean FDA for the use of revaprazan in the treatment of gastritis. Vonoprazan is an agent with a faster and longer lasting action, marketed in Japan in 2015.
Health Canada has concluded that there is no health risk to Canadians from use of available soy and oyster sauces. Because continuous lifetime exposure to high levels of 3-MCPD could pose a health risk, Health Canada has established 1.0 part per million (ppm) as a guideline for importers of these sauces, in order to reduce Canadians' long-term exposure to this chemical. This is considered to be a very safe level.
=== Libraries and archives === The main library is located in the city centre, named after the writer Armand Salacrou. It has branches in all districts. A new multimedia library at the "Volcano" is being refurbished for 2014. Thousands of references are available in specialized libraries in the Higher School of Art, the Museum of André Malraux, and the Natural History Museum. Medieval manuscripts and Incunables are conserved at the public library. The archives of the city, at the Fort of Tourneville, possesses documents from the 16th to the 20th centuries.
== Structure == Delta hexatoxin Hv1 is a tightly folded polypeptide that contains a chain of 42 amino acid residues and has the chemical formula C206H318N58O60S9. The amino acid sequence of delta hexatoxin Hv1 is:The tertiary structure of δ-ACTX-Hv1 contains a core β region that is made up of the residues Cys1–Cys8, Cys14–Val21, and Ser30–Ser33, with Tyr22–Gly29 protruding outwards. The β region has a three-stranded antiparallel β sheet comprising Asn6–Trp7 (β1), Met18–Val21 (β2), and Ser30–Ser33 (β3). The C-terminal end of the short β1 is held in place by a bifurcated hydrogen bond between the Cys8 amide proton and the carbonyl oxygens of the two residues preceding β strand 3 (Gln28 and Gly29). The β region also contains type II β turns at Lys3–Asn6 and Cys15–Met18 with a rare cis peptide bond at Cys16–Met 17. The nonpolar C-terminal 310 helix formed by Ile35–Lys41, bordering Lys40 and Lys41 and connecting to β region with a disulphide bond next to a β turn. The β region contains hydrophobic cysteine sidechains bordered by a lysine sidechain.Three of the four disulphide bonds form the ICK. The structure of the cystine knot motif found in versutoxin is similar to the one found in gurmarin, a 35-residue plant polypeptide used to test the inhibition of sweet taste receptors.
== Application == The application of APPI with LC/MS is commonly used for analysis of low polarity compounds such as petroleums, polyatomic hydrocarbons, pesticides, steroids, lipids, and drug metabolites lacking polar functional groups. Excellent review articles can be found in the References.
Sources: en.wikipedia.org
== Expansions and sequels == Half-Life was followed by an expansion pack, Opposing Force, on November 1, 1999, developed by Gearbox Software. Players control Hazardous Environment Combat Unit (HECU) Corporal Adrian Shephard, who fights a new group of aliens, Race X, and Black Ops units after being split from his team. Gearbox developed a second expansion pack, Blue Shift, in which players control Barney Calhoun, a security guard at Black Mesa, as he attempts to escape the facility. It was developed as a bonus campaign for the Dreamcast port of Half-Life, but was released for Windows on June 12, 2001, after the port was canceled. Gearbox created a cooperative multiplayer expansion pack, Decay, exclusively for the PlayStation 2 port of Half-Life which is played through the perspectives of Gina Cross and Colette Green, two Black Mesa scientists. Half-Life 2 was released in 2004. The player controls Freeman 20 years after the Black Mesa incident in the dystopian City 17, where he joins a rebellion against an alien regime. It was followed by the episodic sequels Half-Life 2: Episode One (2006) and Half-Life 2: Episode Two (2007). After cancelling several other Half-Life projects, Valve released Half-Life: Alyx in 2020.
== Insight into complexation by spectroscopic techniques == The main objective is to elucidate the complexation and extraction mechanisms of a ligand in order to develop a reliable and affordable extraction process at industrial scale. In this perspective, the formation and the stability of different metal-ligand complexes are first investigated by different spectroscopic techniques on a laboratory scale. Preliminary studies can be performed by Electrospray ionization mass spectrometry (ESI-MS) to qualitatively explore the ligand complexes with lanthanides or actinides. Moreover, quantitative information about speciation and complexation of the ligand with some metal ions representatives of actinides and lanthanides can be obtained by Time-resolved fluorescence spectroscopy (TRLFS) experiments.
In September 2022, the ministry reported: "Repair work on the Cinesphere, pods, and bridges is proceeding on schedule this fall. Site servicing, including sewage, water, electrical, and gas, is expected to begin in the spring of 2023." Therme Canada's local partners are the Toronto International Film Festival (TIFF), Mississaugas of the Credit First Nation, and Black North Initiative. TIFF later 'paused' their relationship with Therme ahead of their 2023 festival. Other partners include AECON Group Inc., Diamond Schmitt, and Studio TLA. Strategy Corp is serving Therme Canada with strategy and communications. Swim Drink Fish Canada was a partner, but exited the partnership in the belief that the government's portion of the plan is "simply too opaque and controversial for us to support". Therme's plans have received strong public backlash, with the group Ontario Place for All leading the campaign against the development. Plans to develop the public space and existing beach by a for-profit private developer became a prominent 2023 election issue in Toronto. The mayoral campaign saw mayor Olivia Chow come out in opposition to the project. Later in 2023, she dropped her opposition to the project when the City and Government of Ontario reached an agreement for the transfer of the two Toronto freeways (Don Valley and Gardiner) to the province, saving the city an estimated $1.2 billion. The community group has continued its opposition, attempting to stop or slow down the project in the courts.
Based on the findings for how galectin-7 is used for and against tumors, the therapeutic implications are how it can be used for future gene-therapy targeting to force the expression of the protein in tumor cells for suppression of tumor growth, though this can only be used in certain cancers that don't rely on over expression of galectins to grow. The protein has potential to be a biomarker in low expression as well as preventing aggressive tumor behavior.
Sources: en.wikipedia.org
No regulator in a major market has approved it for human use. It appears in research settings and in products marketed outside pharmacy channels. Legal status for personal possession varies by country.
Afamelanotide is a linear analog that has received approval in some jurisdictions for a specific photoprotection indication. Melanotan II is cyclic and less selective across melanocortin receptors. The two are related but are not interchangeable in regulatory or clinical terms.
A compound that activates several receptor subtypes may produce effects beyond pigmentation. Selectivity influences which tissues respond and shapes the side-effect profile described in reports. Designing subtype-selective analogs is a stated goal of melanocortin research.
It is a synthetic cyclic heptapeptide and an analogue of alpha-melanocyte-stimulating hormone. The molecule is produced by chemical synthesis rather than extracted from a biological source.